Bioequivalence of Tagamet Tablet to Sinil CIMETIDINE Tablet (cimetidine 400 mg) |
Yoon, Mi-Kyeong
(College of Pharmacy, Chung-Ang University)
Lee, Byoung-Moo (College of Pharmacy, Chung-Ang University) Lee, Sung-Jae (College of Pharmacy, Chung-Ang University) Kim, Sun-Kyu (College of Pharmacy, Chung-Ang University) Lee, Jae-Hwi (College of Pharmacy, Chung-Ang University) Choi, Young-Wook (College of Pharmacy, Chung-Ang University) |
1 | J. Hempenius et al., High-throughput solid-phase extraction for the detennination of cimetidine in human plasma, Journal of Chromatography. B, 714, 361-368 (1998) |
2 | USP 24, General Information <1090> In VIvo Bioequivalene Guidances; Cimetidine Tablets - In VIvo Bioequivalence and In VItro Dissolution Testing, 2069-2070 (1999) |
3 | Jiunn H. Lin, Pharmacokinetic and pharmacodynamic properties of histamine Hrreceptor antagonists, Clinical Pharmacokinetics, 20, 218-239 (1991) DOI ScienceOn |
4 | 식품의약품안전청 고시 제2002-60호 (2002. 11. 22). 생물학적동등성시험기준. |
5 | Review of in vivo bioequivalence studies, dissolution data and waiver request, FDA website, CDER application Number 074568 (1995) |
6 | S.G. Park, J.Y. Lee, S.U. Choi, M.K. Yoon, J. Lee and yw. Choi, Statistical Interpretation of Bioequivalence in 2 x 2 Crossover Design with Missing Observations, The Journal of Korean Pharmaceutical Sciences, 34, 215-222 (2004) |
7 | A.M. Rustum and N.B. Hoffman, Liquid chromatographic detennination of cimetidine in whole blood and plasma by using short polymeric phase column, Journal of the Association of Official Agricultural Chemists, 71, 519-522 (1988) |
8 | Y.J. Lee, Y.G. Kim, M.G. Lee, S.J. Chung, M.H. Lee and C.K. Shim, Analysis of bioequivalence study using logtransformed model, Yakhakhoeji, 44, 308-314 (2000) |
9 | H.I. Patel, Analysis of incomplete data in a two-period crossover design with reference to clinical trials, Biometrika, 72,411-418 (1985) DOI ScienceOn |